Matthias Hebrok, PhD, senior author of new study that transformed human stem cells into mature, insulin-producing cells. Photo courtesy of UCSF. More often than not, people don't really think about their blood sugar levels before sitting down to enjoy a delicious meal, partake in a tasty dessert, or go out for a bicycle ride. But … Continue reading Breakthrough for type 1 diabetes: scientist discovers how to grow insulin-producing cells
Basic Research
Stem Cells make the cover of National Geographic
National Geographic is one of those iconic magazines that everyone knows about but few people read. Which is a shame, because it's been around since 1888 and has helped make generations of readers aware about the world around them. And now, it's shifting gears and helping people know more about the world inside them. That's … Continue reading Stem Cells make the cover of National Geographic
Performance, Passion and Progress: and that’s just page one of our 2018 Annual Report
It’s hard to sum up the activities and achievements of a year in a single document, let alone one that’s just 24 pages. But that’s what we have done in putting together our 2018 Annual Report. It’s a look back at the year just gone, the highlights, the low lights (spoiler alert – there weren’t … Continue reading Performance, Passion and Progress: and that’s just page one of our 2018 Annual Report
Midwest universities are making important tools to advance stem cell research
Two Midwest universities are making headlines for their contributions to stem cell research. Both are developing important tools to advance this field of study, but in two unique ways. Scientists at the University of Michigan (UM), have compiled an impressive repository of disease-specific stem cell lines. Cell lines are crucial tools for scientists to study … Continue reading Midwest universities are making important tools to advance stem cell research
NIH-scientists are told to stop buying fetal tissue for research, highlighting importance of CIRM’s voter-created independence
The news that President Trump’s administration has told scientists employed by the National Institutes of Health (NIH) that they can’t buy any new human fetal tissue for research has left many scientists frustrated and worried. The news has also highlighted the reason why voters created CIRM in the first place and the importance of having … Continue reading NIH-scientists are told to stop buying fetal tissue for research, highlighting importance of CIRM’s voter-created independence
CIRM-funded research is helping unlock the secrets behind “chemo brain”
Every year millions of Americans undergo chemotherapy. The goal of the treatment is to destroy cancer, but along the way more than half of the people treated lose something else. They suffer from something called “chemo brain” which causes problems with thinking and memory. In some cases it can be temporary, lasting a few months. … Continue reading CIRM-funded research is helping unlock the secrets behind “chemo brain”
CIRM invests $1.3 million to study stem cells in metabolic liver disease
Metabolic liver disease, is an emerging public health concern in Western countries, but has largely been overshadowed by health issues such as cancer and diabetes. Chronic liver disease (of which metabolic liver disease is a significant contributor) however, is a significant public health concern, evidenced by its contribution to nearly 2 million deaths per year … Continue reading CIRM invests $1.3 million to study stem cells in metabolic liver disease
Stories that caught our eye: SanBio’s Traumatic Brain Injury trial hits its target; A new approach to endometriosis; and a SCID kid celebrates Halloween in style
Hopeful signs for treating brain injuries There are more than 200,000 cases of traumatic brain injury (TBI) in the US every year. The injuries can be devastating, resulting in everything from difficult sleeping to memory loss, depression and severe disability. There is no cure. But this week the SanBio Group had some encouraging news from … Continue reading Stories that caught our eye: SanBio’s Traumatic Brain Injury trial hits its target; A new approach to endometriosis; and a SCID kid celebrates Halloween in style
Mechanical forces are the key to speedy recovery after blood cancer treatment
Blood cancers, such as leukemia and lymphoma, are projected to be responsible for 10% of all new cancer diagnoses this year. These types of cancers are often treated by killing the patient’s bone marrow (the site of blood cell manufacturing), with a treatment called irradiation. While effective for ridding the body of cancerous cells, this … Continue reading Mechanical forces are the key to speedy recovery after blood cancer treatment
Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
While we have made great progress in developing therapies that control the AIDS virus, HIV/AIDS remains a chronic condition and HIV medicines themselves can give rise to a new set of medical issues. That’s why the Board of the California Institute for Regenerative Medicine (CIRM) has awarded $3.8 million to a team from City of Hope … Continue reading Stem Cell Agency Invests in New Immunotherapy Approach to HIV, Plus Promising Projects Targeting Blindness and Leukemia
The Stem Cellar 